Voisin Consulting Life Sciences (VCLS)’s Post

📰 We have interesting factsheets for key stakeholders! Discover the latest #HumanMicrobiomeAction factsheets designed for various stakeholders in microbiome science and beyond. 🦠 Whether you're a #healthcare practitioner, a #policymaker, or a #industry specialist, explore the fascinating world of microbiome science. ⚕️⚖️🔬 Explore the fascinating world of your microbiome by reading these informative articles 👇 Meanwhile, mark your calendars for our upcoming final conference! Register here to secure your spot, engage with experts and participate in this enlightening experience 🎟️ ⏩ https://lnkd.in/eXyszcBe

During #MIGlobal 2024, our health team launched key initiatives and highlighted ongoing programmatic work in more than two dozen panels featuring leaders across industries and sectors. They discussed a variety of critical health-related topics, including the need for simplified and accessible clinical trials for diverse patients and clinicians in various settings. Patient engagement throughout the product development life cycle—from design to evidence generation—is important for ensuring treatments meet patients’ needs. Building trust with diverse communities is vital for successful clinical research that is generalizable to all populations and requires long-term community engagement and addressing historical harms. Involving underserved communities in all stages of research, from question formulation to dissemination of results, is essential for addressing health disparities. Watch the “Revolutionizing Research: Democratizing Clinical Trials” panel: https://lnkd.in/dt8eXvWr Watch “Health Economics Driving New Investments” panel: https://lnkd.in/e2p3-68C Read more about MI Health at #MIGlobal here: https://lnkd.in/g6JpgZCv #health #healthcare #leadership #trend

In December, the Nova Annual Conference brought together leaders and experts across fields to explore the many interconnected factors that influence health and vitality. Collaborations formed in real time as scientists, researchers, and even artisans came together to explore topics such as food and nutrition, corporate accountability, well-being economies, and how to overcome barriers that limit the exposure of their important work. "Together, in real-time, strands are woven. Questions arise, with answers that might be obtained by novel research or critical policy approaches. The tapestry of health emerges." Read reflections from President and Founder Professor Brian Berman, MD, and see videos from the conference: https://ow.ly/BMOv50QHk0O

📢 Excited to Announce the Release of Our Latest Report! 📢 After months of dedicated research and collaboration, I'm thrilled to share the report, "An Incomplete Picture: Understanding the Burden of Long COVID," created by Economist Impact and supported by Pfizer. This comprehensive study dives deep into the societal, economic, and health system challenges posed by Long COVID, shedding light on its far-reaching impacts on patients and healthcare systems globally. Key Highlights: 🔹 In-depth analysis of Long COVID's prevalence and the varying symptoms that patients experience. 🔹 Emerging best practices in Long COVID care, emphasizing the need for multidisciplinary, patient-centered approaches. 🔹 Insightful country profiles and case studies that highlight national priorities and local healthcare system responses. 🔹 A call to action for policymakers and stakeholders to develop integrated policy frameworks and prioritize comprehensive data collection. A special shoutout to Miranda Baxa, MPH, Latifat Okara, and Alcir Santos Neto for their exceptional work and dedication as the research management team. Your leadership and insights were crucial in bringing this report to fruition. This report is an invaluable resource for healthcare professionals, policymakers, and all stakeholders committed to addressing the multifaceted implications of Long COVID. A big thank you to all the experts and contributors whose insights were crucial to this project. Together, we can make a difference and support those affected by Long COVID. 📖 Read the full report here: https://lnkd.in/dQZAyvQu #LongCOVID #Healthcare #Policy #Research #EconomistImpact #Pfizer #PublicHealth

The risk of developing co-morbid conditions is higher in patients with Endometriosis. Read more about what OnaWave Medical have to say about this in the monthly ECHAlliance - The Global Health Connector newsletter https://lnkd.in/eF3PWZMj

Remember this 👉Join us on Sep 30, 13:00-14:00 CET for ERA4Health's 1st webinar with Dr. Calum MacRae on Learning Health Systems for Discovery, Translation and Care!  https://lnkd.in/dzii66RC. 👉Involved in academic multinational trials in Europe? We have developed a survey for you! The goal is to support the harmonisation of EU Clinical Trial Agreement (CTA) to facilitate the conduct of academic multinational clinical trials. https://lnkd.in/dYGZQ_zU 👉 ERA4Health is conducting a comprehensive survey to identify challenges in translating health research into practical applications. Help us overcome roadblocks and improve health outcomes across the EU and beyond. Your participation matters! 🌍 https://lnkd.in/dDcZRw-a #ERA4Health, #HealthInnovation, #LearningHealthSystems, #CalumMacRae #TranslationalResearch ECRIN (European Clinical Research Infrastructure Network) ILVO (Instituut voor Landbouw, Visserij- en Voedingsonderzoek)

This June, for International MASH Day, Biopharma Informatic underscores the urgency of addressing MASH as a global health crisis. Together, let's pave the way for innovative solutions and a healthier future. #MASHday #StepUpForMASH #LiverHealth #Biopharmainformatic #MASHstudies #clinicaltrials #research

We are at the very dawn of the reality of precision health. Guaranteed this happens within our lifetimes. It’s accelerating faster than most people realize and the inflection is unlike anything we’ve ever seen in the delivery and maintenance of human health throughout history. This will be the century of biology. It’s complex though. Are we asking the right questions? Do we have the right tools to ask these questions at scale? Can we understand what the answers mean (the “so what”)? and then, most importantly, can we actually deliver it. The last one is the hardest piece.

What will it take to make precision health a global reality? This month, Nature Medicine presents a special Focus dedicated to precision health. As healthcare becomes increasingly data-driven and precise, we ask what it means to deliver precision health — that is, the tailoring of preventive or treatment approaches to groups or individuals on the basis of certain characteristics — in different geographical and clinical contexts. This issue includes a variety of news, opinion, review and original research articles on critical areas and challenges that must be addressed to make precision health a global reality. Read it now online in Nature Medicine #precisionhealth #healthcare #sustainability #genomics #precisionmedicine #globalhealth

🚫 The Harsh Reality: My team made a groundbreaking discovery, identifying specific patients who would 100% respond to a particular cancer drug. This should have been a triumph for precision health, a step toward personalized treatment. Instead, the marketing team chose to pull the diagnostic tool that could have ensured precise treatment, all to avoid a potential $1 billion annual loss in sales. Precision medicine, with its potential to revolutionize healthcare, remains a distant dream as long as financial gains take precedence over patient well-being. #precisionhealth #precisionmedicine